235 related articles for article (PubMed ID: 27287605)
1. Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.
Anjum S; Muzaale AD; Massie AB; Bae S; Luo X; Grams ME; Lentine KL; Garg AX; Segev DL
Am J Transplant; 2016 Dec; 16(12):3540-3547. PubMed ID: 27287605
[TBL] [Abstract][Full Text] [Related]
2. Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.
Massie AB; Holscher CM; Henderson ML; Fahmy LM; Thomas AG; Al Ammary F; Getsin SN; Snyder JJ; Lentine KL; Garg AX; Segev DL
JAMA Surg; 2020 Mar; 155(3):e195472. PubMed ID: 31968070
[TBL] [Abstract][Full Text] [Related]
3. Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease.
Muzaale AD; Massie AB; Anjum S; Liao C; Garg AX; Lentine KL; Segev DL
Am J Transplant; 2016 Dec; 16(12):3532-3539. PubMed ID: 27172445
[TBL] [Abstract][Full Text] [Related]
4. Association Between Living Kidney Donor Postdonation Hypertension and Recipient Graft Failure.
Holscher CM; Ishaque T; Haugen CE; Jackson KR; Garonzik Wang JM; Yu Y; Al Ammary F; Segev DL; Massie AB
Transplantation; 2020 Mar; 104(3):583-590. PubMed ID: 32106202
[TBL] [Abstract][Full Text] [Related]
5. GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.
Matas AJ; Vock DM; Ibrahim HN
Am J Transplant; 2018 Mar; 18(3):625-631. PubMed ID: 28980397
[TBL] [Abstract][Full Text] [Related]
6. Obesity increases the risk of end-stage renal disease among living kidney donors.
Locke JE; Reed RD; Massie A; MacLennan PA; Sawinski D; Kumar V; Mehta S; Mannon RB; Gaston R; Lewis CE; Segev DL
Kidney Int; 2017 Mar; 91(3):699-703. PubMed ID: 28041626
[TBL] [Abstract][Full Text] [Related]
7. Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.
Holscher CM; Ishaque T; Garonzik Wang JM; Haugen CE; DiBrito SR; Jackson KR; Muzaale AD; Massie AB; Al Ammary F; Ottman SE; Henderson ML; Segev DL
Am J Transplant; 2018 Nov; 18(11):2804-2810. PubMed ID: 30086198
[TBL] [Abstract][Full Text] [Related]
8. Causes and timing of end-stage renal disease after living kidney donation.
Matas AJ; Berglund DM; Vock DM; Ibrahim HN
Am J Transplant; 2018 May; 18(5):1140-1150. PubMed ID: 29369517
[TBL] [Abstract][Full Text] [Related]
9. Renal Consequences of Diabetes After Kidney Donation.
Ibrahim HN; Berglund DM; Jackson S; Vock DM; Foley RN; Matas AJ
Am J Transplant; 2017 Dec; 17(12):3141-3148. PubMed ID: 28681494
[TBL] [Abstract][Full Text] [Related]
10. Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors.
Muzaale AD; Althoff KN; Sperati CJ; Abraham AG; Kucirka LM; Massie AB; Kitahata MM; Horberg MA; Justice AC; Fischer MJ; Silverberg MJ; Butt AA; Boswell SL; Rachlis AR; Mayor AM; Gill MJ; Eron JJ; Napravnik S; Drozd DR; Martin JN; Bosch RJ; Durand CM; Locke JE; Moore RD; Lucas GM; Segev DL
Am J Transplant; 2017 Jul; 17(7):1823-1832. PubMed ID: 28497525
[TBL] [Abstract][Full Text] [Related]
11. Risk of end-stage renal disease following live kidney donation.
Muzaale AD; Massie AB; Wang MC; Montgomery RA; McBride MA; Wainright JL; Segev DL
JAMA; 2014 Feb; 311(6):579-86. PubMed ID: 24519297
[TBL] [Abstract][Full Text] [Related]
12. A Case-Based Analysis of Whether Living Related Donors Listed for Transplant Share ESRD Causes with Their Recipients.
Matas AJ; Hays RE; Ibrahim HN
Clin J Am Soc Nephrol; 2017 Apr; 12(4):663-668. PubMed ID: 28249957
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease.
Muzaale AD; Massie AB; Kucirka LM; Luo X; Kumar K; Brown RS; Anjum S; Montgomery RA; Lentine KL; Segev DL
Transplantation; 2016 Jun; 100(6):1306-12. PubMed ID: 26457599
[TBL] [Abstract][Full Text] [Related]
14. Implications of excess weight on kidney donation: Long-term consequences of donor nephrectomy in obese donors.
Serrano OK; Sengupta B; Bangdiwala A; Vock DM; Dunn TB; Finger EB; Pruett TL; Matas AJ; Kandaswamy R
Surgery; 2018 Nov; 164(5):1071-1076. PubMed ID: 30149934
[TBL] [Abstract][Full Text] [Related]
15. Hypertension after kidney donation: Incidence, predictors, and correlates.
Sanchez OA; Ferrara LK; Rein S; Berglund D; Matas AJ; Ibrahim HN
Am J Transplant; 2018 Oct; 18(10):2534-2543. PubMed ID: 29498216
[TBL] [Abstract][Full Text] [Related]
16. Renal Function Profile in White Kidney Donors: The First 4 Decades.
Ibrahim HN; Foley RN; Reule SA; Spong R; Kukla A; Issa N; Berglund DM; Sieger GK; Matas AJ
J Am Soc Nephrol; 2016 Sep; 27(9):2885-93. PubMed ID: 26888476
[TBL] [Abstract][Full Text] [Related]
17. Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.
Holscher CM; Bae S; Thomas AG; Henderson ML; Haugen CE; DiBrito SR; Muzaale AD; Garonzik Wang JM; Massie AB; Lentine KL; Segev DL
Transplantation; 2019 Jun; 103(6):1216-1223. PubMed ID: 30247449
[TBL] [Abstract][Full Text] [Related]
18. The association of predonation hypertension with glomerular function and number in older living kidney donors.
Lenihan CR; Busque S; Derby G; Blouch K; Myers BD; Tan JC
J Am Soc Nephrol; 2015 Jun; 26(6):1261-7. PubMed ID: 25525178
[TBL] [Abstract][Full Text] [Related]
19. Risk of ESRD in prior living kidney donors.
Wainright JL; Robinson AM; Wilk AR; Klassen DK; Cherikh WS; Stewart DE
Am J Transplant; 2018 May; 18(5):1129-1139. PubMed ID: 29392849
[TBL] [Abstract][Full Text] [Related]
20. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation.
Lentine KL; Lam NN; Schnitzler MA; Hess GP; Kasiske BL; Xiao H; Axelrod D; Garg AX; Schold JD; Randall H; Dzebisashvili N; Brennan DC; Segev DL
Am J Transplant; 2017 Mar; 17(3):744-753. PubMed ID: 27589826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
